glp 1 effect on heart Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide | Cardiovascular Diabetology GLP-1 receptor agonists and myocardial

Alabamas attorney general recently filed a lawsuit against a medical spa alleging that it administered unapproved versions of GLP-1 weight loss drugs to patients without informing them that the formulations were not authorized by the FDA

GLP-1 medicines and foods can help pets loose 5% of their weight in 3 months

To report a case of non-arteritic ischemic optic neuropathy (NAION) in an otherwise healthy patient treated with Glucagon-Like Peptide-1 (GLP-1) receptor agonists (RAs) liraglutide and semaglutide

The answer depends on your individual metabolism, lifestyle changes, and weight regain risk

We also present practical implications of these glucose-lowering agents for reducing the risk of adverse cardiovascular events and progressive renal comorbidity in patients with T2D and CVD.

Members of $MED's Scientific and Clinical Affairs team and Medifasts Scientific Advisory Board recently published an article in Diabetes, Obesity and Metabolism, highlighting GLP-1 discontinuation rates